845 filings
4
Stephen L Silvestro
6 May 24
OptimizeRx / Stephen L Silvestro ownership change
9:35pm
4/A
Stephen L Silvestro
6 May 24
OptimizeRx / Stephen L Silvestro ownership change
9:34pm
4/A
Stephen L Silvestro
6 May 24
OptimizeRx / Stephen L Silvestro ownership change
9:32pm
8-K
OPRX
OptimizeRx Corp
29 Apr 24
1Q24 revenue expected to grow over 40% year-over-year and come in between
4:30pm
ARS
2023 FY
OPRX
OptimizeRx Corp
29 Apr 24
Annual report to shareholders
8:38am
4
f9y4dclc4x65
24 Apr 24
OptimizeRx / WILLIAM J FEBBO ownership change
10:20am
4
owoywjzmt99q23v9k0
24 Apr 24
OptimizeRx / Doug Besch ownership change
10:18am
4
dr4fux
24 Apr 24
OptimizeRx / Marion Odence-Ford ownership change
10:17am
4
zawquh2ih4fu48 8otck
24 Apr 24
OptimizeRx / Edward Stelmakh ownership change
10:16am
4
zpm77hvr7zxhrunoajg
24 Apr 24
OptimizeRx / Stephen L Silvestro ownership change
10:04am
4/A
latgi8l elf8
22 Apr 24
OptimizeRx / Edward Stelmakh ownership change
8:37am
4/A
u4o16e7lf0 cr0ef
22 Apr 24
OptimizeRx / Edward Stelmakh ownership change
8:31am
8-K
16mqjne 5judus1
18 Apr 24
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
4:30pm
4
1rs6plp3qp3 gk0bpo3
17 Apr 24
OptimizeRx / WILLIAM J FEBBO ownership change
5:22pm
8-K
t64225f
2 Apr 24
Entry into a Material Definitive Agreement
4:05pm
NT 10-K
zdxweiob
28 Mar 24
Notice of late annual filing
8:15am
8-K
jf00zic9b4e883w5i
11 Mar 24
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
5:04pm
4
pfl4ln
6 Mar 24
OptimizeRx / Stephen L Silvestro ownership change
4:20pm